-
Product Insights
NewLikelihood of Approval Analysis for Systemic Sclerosis (Scleroderma)
Overview How likely is it that the drugs in Systemic Sclerosis (Scleroderma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic Sclerosis (Scleroderma) Overview Scleroderma is a group of rare diseases...
-
Product Insights
NewLikelihood of Approval Analysis for Atherosclerosis
Overview How likely is it that the drugs in Atherosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atherosclerosis Overview Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries...
-
Product Insights
NewLikelihood of Approval Analysis for Arteriosclerosis
Overview How likely is it that the drugs in Arteriosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteriosclerosis Overview Arteriosclerosis refers to the thickening and hardening of arteries due to...
-
Product Insights
NewLikelihood of Approval Analysis for Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Overview How likely is it that the drugs in Coronary Artery Disease (CAD) (Ischemic Heart Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Coronary Artery Disease (CAD) (Ischemic Heart Disease)...
-
Product Insights
United Kingdom (UK) SME Insurance Market Size, Trends, Competitor Dynamics and Opportunities
United Kingdom (UK) SME Insurance Market Report Overview The UK SME insurance market generated gross written premiums (GWP) worth GBP15.52 billion in 2023. The primary factor contributing to GWP growth in 2023 was a large year-round hardening of premiums. The rise in claims expenses, which were often passed on to customers, also contributed to the overall increase in GWP. Various insurance categories witnessed substantial increases in the cost of coverage, primarily due to inflationary pressures and challenges in the global...
-
Sector Analysis
United Kingdom (UK) Commercial Property Insurance Market Trends, Competitor Dynamics and Opportunities
The gross written premium (GWP) in the UK commercial property insurance market was valued at GBP12.2 billion in 2022. The commercial property insurance market in the UK is predicted to expand gradually at a CAGR of more than 4% from 2022 to 27. It is projected that factors such as rising repair costs and hardening market rates will fuel premium increases in the coming years. UK Commercial Property Insurance Market Outlook 2022-2027 (GBP Billion) Buy The Full Report for More...
-
Product Insights
Hill&Hall – Harden Road Residential Community – Walsall
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hill&Hall - Harden Road Residential Community - Walsall report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
Drummond Co – Harden Boulevard Mixed-Use Complex – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Drummond Co - Harden Boulevard Mixed-Use Complex - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Harden/ Wal-Mart – Vaudreuil-Dorion Fulfillment Center – Quebec
Equip yourself with the essential tools needed to make informed and profitable decisions with our Harden/ Wal-Mart - Vaudreuil-Dorion Fulfillment Center - Quebec report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Company Profile
Darktrace Holdings Ltd – Company Profile
Darktrace Holdings Ltd (Darktrace) is a cyber security artificial intelligence company that develops solutions to detect and prevent advanced cyber threats. The company offers Darktrace PREVENT provides visibility, Darktrace DETECT is a revolutionary self-learning AI for cyber security and Darktrace RESPOND detects and responds to unpredictable and novel cyber threats. Its Darktrace HEAL is an artificial engine that interacts continuously with other cyber capabilities as it autonomously hardens Darktrace DETECT and Darktrace RESPOND with new feedback. The company operates in...
Add to Basket